Canadian photonic quantum computing company Xanadu Quantum Technologies (NASDAQ: XNDU) reported its third-quarter results on November 11, 2026. Revenue was $1.3 million and net loss was $32.2 million. Although the net loss narrowed from the previous quarter, quarter-end cash stood at $286.5 million, down $26.3 million over three months. If that pace continues, current cash covers about 10.9 quarters, running out around mid-2029. The company aims to build a quantum computer with up to 200 logical qubits in 2029, so securing funding to reach that goal is a key challenge.
Net loss narrowed, but underlying losses grew as R&D spending rose
According to figures presented by CFO Michael Trzupek on the earnings call, third-quarter revenue was $1.3 million, down from $1.5 million in the previous quarter. It was up from $1.0 million a year earlier, but the business remains small. R&D expenses, meanwhile, rose $5.9 million from the previous quarter to about $25.6 million. The main drivers were wafer purchases, development of manufacturing processes at a new foundry, joint development with GlobalFoundries, and hiring of engineers. General and administrative expenses fell to about $9.2 million from $11.1 million in the previous quarter.
Net loss narrowed from $42.1 million in the previous quarter to $32.2 million. However, this did not come from improved operating results. According to the CFO, the previous quarter included a $10.6 million loss from changes in the fair value of a liability tied to contingently issuable shares (the earn-out share liability) and a $1.9 million derivative loss related to the stock sales facility. Neither occurred this quarter. Excluding these accounting effects, profitability actually deteriorated. Adjusted EBITDA was a loss of $26.3 million, a $5.0 million wider loss than the $21.3 million in the previous quarter.
Capital expenditures also reached $8.4 million as the build-out of its development operations continued. Headcount rose by 55, from 306 at the end of the previous quarter to 361. CEO Christian Weedbrook has said that at the company's current stage, progress on its quantum hardware roadmap and the building of partnerships matter more than quarterly revenue. But revenue is nowhere near covering R&D costs, so how long development can continue depends heavily on cash on hand and future fundraising.
Current cash lasts until mid-2029, overlapping with the quantum computer development target
Cash at the end of the third quarter was $286.5 million, down $26.3 million from $312.8 million at the end of the previous quarter. No funds were raised through the company's stock sales facility during the quarter.
Assuming cash continues to fall at the third-quarter pace, current funds would last about 10.9 quarters. This is a simple calculation, dividing $286.5 million in cash by the quarterly decline of $26.3 million, and implies funds running out around June 2029, about 33 months after the end of September 2026. The estimate does not factor in future fundraising or increases in R&D spending.
The issue is that this timing coincides with a key milestone on Xanadu's technology roadmap. The company targets up to 200 logical qubits in 2029, up to 500 in 2030, and 1,000 or more from 2031 onward. Logical qubits are qubits that use quantum error correction to suppress errors and enable reliable computation. Weedbrook has outlined plans to bring a commercially viable quantum computer to market in 2029–2030. If the current rate of cash decline continues, cash on hand would be nearly exhausted by the time the first major development target is reached.
Furthermore, the $26.3 million decline in cash does not represent total spending. Adding capital expenditures of $8.4 million to the adjusted EBITDA loss of $26.3 million gives $34.7 million, which exceeds the actual cash decline. Changes in working capital and non-cash expenses may account for the difference, but a detailed breakdown was not provided on the earnings call. If $34.7 million per quarter were treated as the cash burn, cash would cover about 8.3 quarters, running out around October 2028. However, adjusted EBITDA plus capital expenditures differs from actual cash flow, so this is only a reference figure for gauging the scale of the funding burden.
Spending could increase further. The CFO explained that in the fourth quarter, both expenses and capital expenditures will rise due to payments to GlobalFoundries, hiring, and equipment purchases. Xanadu, however, has a policy of not publishing forward guidance, so the specific size of the increase is unknown. The mid-2029 estimate is therefore a rough guide assuming the current pace of cash decline continues, not a confirmed date for when funds will run out.
A stock sales facility of about $232.8 million and government support underpin funding
Xanadu does have additional sources of funding, so judging its development runway from current cash alone would be inappropriate. According to the CFO, about $232.8 million remains unused on the stock sales facility, which raised $67.2 million in the second quarter. Under this arrangement, which the company calls a "synthetic ATM," it sold 5.5 million shares at an average net price of $12.28 in the second quarter, raising $67.2 million. The earnings call did not explain how the mechanism works in detail.
If the remaining capacity could be fully used, the company would have about $519.3 million in funds together with current cash. At the same quarterly cash decline of $26.3 million, that equals about 19.7 quarters, extending the runway to around summer 2031. However, because this is funding raised through stock sales, the amount actually obtained depends on market conditions, the share price, and other factors. Additional share issuance would also dilute existing shareholders' ownership.
Government funding has also been arranged. Xanadu has signed a formal agreement with the Canadian federal government for about $140 million in funding. The money will go toward developing a new facility in Toronto called "Inception" (158,000 square feet, about 14,700 square meters) and other purposes. It will not be paid upfront in a lump sum, however, but disbursed in stages as eligible R&D investments are made. The full contract amount therefore cannot be treated as immediately available cash. In addition, up to $10 million in further funding has been provisionally approved under the U.S. Defense Advanced Research Projects Agency (DARPA) Quantum Benchmarking Initiative (QBI).
Given these funding options, there is a good chance Xanadu can keep developing beyond 2029. The estimate that cash on hand lasts only until mid-2029 and the estimate that additional funding could secure money until around 2031 are not contradictory. The latter assumes the stock sales facility can actually be used and does not account for future cost increases. What matters is how much additional funding, and on what terms, the company needs to secure to carry out its current development plan.
Next earnings: cash burn; in 2027: optical loss improvement in focus
The next quarterly results will be an important data point for judging future funding. What to watch is the underlying decline in cash, excluding cash increases from stock sales or government funding receipts. If that figure falls below $20 million, the runway at the same pace would extend beyond mid-2029, and the point at which additional fundraising becomes pressing would move back. If it exceeds $30 million, spending is accelerating and cash would run out sooner. Checking the amount drawn on the stock sales facility and government funds received alongside it would show how much the company relies on external funding to operate.
On the technology side, improvement in optical component losses remains a key metric. The aggregate metric in Xanadu's optical loss roadmap evaluates the loss of each of 17 key optical components as a ratio to the level needed for fault tolerance and sums them. The lower the number, the closer the company is to its target. Weedbrook said the company will change how often it publishes this aggregate figure from quarterly to annually. It is expected to reach 10.2x in early 2027, with the next update scheduled for the first quarter of 2027.
Improvements have already been confirmed in individual optical components. The insertion loss of the electro-optic switch fell to 7 millidB (0.007 dB), a sharp drop from the roughly 20 millidB reported the previous year. Xanadu says this is the lowest loss among published switches in its class. However, this is the company's own claim and does not directly demonstrate improved performance of a quantum computer as a whole.
Collaboration with Japanese companies is also advancing. With Mitsubishi Chemical, Xanadu carried out a demonstration modeling photosensitive materials used in semiconductor EUV lithography with quantum algorithms. JSR has also signed a statement of work for a feasibility study. Such efforts are important for broadening industrial uses of quantum computing, but third-quarter revenue of $1.3 million is not large enough to offset the $26.3 million quarterly decline in cash.
Xanadu's finances are at a stage where technological progress and the need for funding are rising together. Assuming the current pace of cash decline, cash on hand alone would last until mid-2029, and full use of the stock sales facility could extend that to around summer 2031 as a rough guide. At the next earnings report, the underlying cash decline and additional fundraising will help gauge financial progress, and in the first quarter of 2027, the improvement in the optical loss metric will help gauge technical progress.